Non-small cell lung cancer (NSCLC)

August 25, 2015August 25, 2015

DelMar Pharmaceuticals Will Present VAL-083 Lung Cancer Clinical Strategy

Lung Cancer, News

DelMar Pharmaceuticals, Inc., a biopharmaceutical firm focused on the advancement and commercialization of novel cancer therapies, recently announced it has been invited to present a clinical strategy overview concerning VAL-083 (dianhydrogalactitol) and its potential as a treatment for patients ... Read more

June 25, 2015June 25, 2015

Guardant Health Partners With National Cancer Institute On Development of Prospective NSCLC Liquid Biopsy Study

Lung Cancer, News

Guardant Health recently announced a partnership with the National Cancer Institute, a cancer research SWOG funded consortium, in order to identify the mechanisms of resistance and future treatment options to address patients suffering with ... Read more

June 4, 2015June 4, 2015

FDA Accepts Supplemental Biologics License Application For KEYTRUDA

Lung Cancer, News

Merck recently announced that the U.S. Food and Drug Administration (FDA) has agreed to review a supplemental Biologics License Application (sBLA) for the company’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab), with the ... Read more

May 7, 2015May 7, 2015

New Approach To NSCLC Profiling For Efficient Treatment

Lung Cancer, News

Researchers at The University of Manchester in the UK have recently developed a new way to genetically categorize lung cancer samples so that doctors and physicians can effectively opt for targeted ... Read more

April 9, 2015April 9, 2015

XBiotech Publishes Positive Results For Xilonix™ In Non-Small Cell Lung Cancer

Lung Cancer, News

The developer of True Human™ therapeutic antibodies, XBiotech Inc. recently announced the results of a clinical trial for non-small cell lung cancer (NSCLC) in which patients were treated with the Company’s lead True Human antibody, Xilonix™. The ... Read more

April 7, 2015April 7, 2015

Eli Lilly Releases Medicare Treatment and Cost Patterns Among Non-Small Cell Lung Cancer Patients

Lung Cancer, News

In a recent study entitled “Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer,” researchers summarize the current state of metastatic squamous ... Read more